III 

111TH CONGRESS 

2D SESSION S. RES. 508 

Recognizing June 2010 as National Hereditary Hemorrhagic Telangiecstasia 

(HHT) month established to increase awareness of HHT, which is a 

complex genetic blood vessel disorder that affects approximately 70,000 

people in the United States. 

IN THE SENATE OF THE UNITED STATES 

APRIL 29, 2010 

Mr. JOHNSON (for himself and Mr. BENNETT) submitted the following resolution; which was referred to the Committee on Health, Education, Labor, 

and Pensions 

MAY 26, 2010 

Committee discharged; considered and agreed to 

RESOLUTION 

Recognizing June 2010 as National Hereditary Hemorrhagic 

Telangiecstasia (HHT) month established to increase 

awareness of HHT, which is a complex genetic blood 

vessel disorder that affects approximately 70,000 people 

in the United States. 

Whereas, according to the HHT Foundation International, 

Hereditary Hemorrhagic Telangiecstasia (HHT), also referred to as Osler-Weber-Rendu Syndrome, is a long-neglected national health problem that affects approximately 70,000 (1 in 5,000) people in the United States 

and 1,200,000 people worldwide; 


tjames on DSKG8SOYB1PROD with BILLS
2 

SRES 508 ATS 

Whereas HHT is an autosomal dominant, uncommon complex genetic blood vessel disorder, characterized by 

telangiectases and artery-vein malformations that occurs 

in major organs including the lungs, brain, and liver, as 

well as the nasal mucosa, mouth, gastrointestinal tract, 

and skin of the face and hands; 

Whereas left untreated, HHT can result in considerable morbidity and mortality and lead to acute and chronic health 

problems or sudden death; 

Whereas according to the HHT Foundation International, 20 

percent of those with HHT, regardless of age, suffer 

death and disability; 

Whereas according to the HHT Foundation International, 

due to widespread lack of knowledge of the disorder 

among medical professionals, approximately 90 percent of 

the HHT population has not yet been diagnosed and is 

at risk for death or disability due to sudden rupture of 

the blood vessels in major organs in the body; 

Whereas the HHT Foundation International estimates that 

20 to 40 percent of complications and sudden death due 

to these ‘‘vascular time bombs’’ are preventable; 

Whereas patients with HHT frequently receive fragmented 

care from practitioners who focus on 1 organ of the body, 

having little knowledge about involvement in other organs 

or the interrelation of the syndrome systemically; 

Whereas HHT is associated with serious consequences if not 

treated early, yet the condition is amenable to early identification and diagnosis with suitable tests, and there are 

acceptable treatments available in already-established facilities such as the 8 HHT Treatment Centers of Excellence in the United States; and 


tjames on DSKG8SOYB1PROD with BILLS
3 

SRES 508 ATS 

Whereas adequate Federal funding is needed for education, 

outreach, and research to prevent death and disability, 

improve outcomes, reduce costs, and increase the quality 

of life for people living with HHT: Now, therefore, be it 

1 Resolved, That the Senate— 

2 (1) recognizes the need to pursue research to 

3 find better treatments, and eventually, a cure for 

4 HHT; 

5 (2) recognizes and supports the HHT Founda6 tion International as the only advocacy organization 

7 in the United States working to find a cure for 

8 HHT while saving the lives and improving the well9 being of individuals and families affected by HHT 

10 through research, outreach, education, and support; 

11 (3) supports the designation of June 2010 as 

12 National Hereditary Hemorrhagic Telangiecstasia 

13 (HHT) month, to increase awareness of HHT; 

14 (4) acknowledges the need to identify the ap15 proximately 90 percent of the HHT population that 

16 has not yet been diagnosed and is at risk for death 

17 or disability due to sudden rupture of the blood ves18 sels in major organs in the body; 

19 (5) recognizes the importance of comprehensive 

20 care centers in providing complete care and treat21 ment for each patient with HHT; 


tjames on DSKG8SOYB1PROD with BILLS
4 

SRES 508 ATS 

1 (6) recognizes that stroke, lung, and brain hem2 orrhages can be prevented through early diagnosis, 

3 screening, and treatment of HHT; 

4 (7) recognizes severe hemorrhages in the nose 

5 and gastrointestinal tract can be controlled through 

6 intervention, and that heart failure can be managed 

7 through proper diagnosis of HHT and treatments; 

8 (8) recognizes that a leading medical and aca9 demic institution estimated that $6,600,000,000 of 

10 1-time health care costs can be saved through ag11 gressive management of HHT in the at-risk popu12 lation; and 

13 (9) encourages the people of the United States 

14 and interested groups to observe and support the 

15 month through appropriate programs and activities 

16 that promote public awareness of HHT and poten17 tial treatments for it. 

Æ 


tjames on DSKG8SOYB1PROD with BILLS